How ignoring trans populations is hampering Africa’s fight against HIV
New research on HIV/AIDS in transgender populations in South Africa is making clear how much more needs to be done to meet the communities’ needs and end the epidemic. Read more.
With polio eradication in sight, WHA fears setbacks
Though the disease is considered endemic in just two countries, the fight to get rid of polio entirely by the end of 2026 is far from a foregone conclusion. Read more.
Will the medical oxygen industry learn a lesson from COVID-19?
The COVID-19 pandemic exposed the lack of equitable access to medical oxygen in low- and middle-income countries, particularly to medical liquid oxygen, or LOX, which is the gold standard of care. Lower-income countries found themselves scrambling to work with the gas companies that produce medical oxygen to patch together even a limited supply. Now advocates […]
Could WHO jumpstart widespread access to obesity medications?
As the World Health Organization prepares to update its Essential Medicines List, some think it’s time for Ozempic, Wegovy and other new weight-loss drugs to make an appearance. Read more.
Regulating India’s generic drugs is a life or death problem for Africa
Africa is more dependent than other nations on India’s low-cost medicines. But regulation is proving to be a deadly conundrum. Read more.
How Germany’s new feminist development policy will affect funding
The announcement that Germany’s development policy and foreign policy will use a feminist lens raises questions about how that will actually impact budget and implementation. Read more.
The climate emergency is turning fragile supply chains into a crisis
Even before catastrophic floods hit Pakistan last year, antiretroviral medicines, or ARV, were in short supply for people in the country living with HIV. Some patients were traveling up to seven hours to receive care and pick up free medicines at government clinics. When the floods began in June, facilities already stretched by the COVID-19 […]
‘Revolutionary’ HIV prevention jab set to expand choices for consumers
Researchers say Cabotegravir or CAB-LA — an injectable long-term form of preexposure prophylaxis, or PrEP — is “one of the most revolutionary breakthroughs in HIV prevention,” and it will help to provide more product choices for consumers. Read more.
At Munich Security Conference, climate change demands attention
While Russia’s war in Ukraine took up much of the oxygen, global south countries refused to go unheard during panels at the German confab. Read more.
Global south watches as South Africa’s Aspen ventures into vaccines
Can the company usher a more favorable environment on the continent while helping address an entrenched procurement system that takes little account of African producers? Read more.